Cargando…

Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration

The liver is unique in regenerative potential, which could recover the lost mass and function after injury from ischemia and resection. The underlying molecular mechanisms of liver regeneration have been extensively studied in the past using the partial hepatectomy (PH) model in rodents, where 2/3 P...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guodong, L. Guo, Grace
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629218/
https://www.ncbi.nlm.nih.gov/pubmed/26579433
http://dx.doi.org/10.1016/j.apsb.2015.01.005
_version_ 1782398551404314624
author Li, Guodong
L. Guo, Grace
author_facet Li, Guodong
L. Guo, Grace
author_sort Li, Guodong
collection PubMed
description The liver is unique in regenerative potential, which could recover the lost mass and function after injury from ischemia and resection. The underlying molecular mechanisms of liver regeneration have been extensively studied in the past using the partial hepatectomy (PH) model in rodents, where 2/3 PH is carried out by removing two lobes. The whole process of liver regeneration is complicated, orchestrated event involving a network of connected interactions, which still remain fully elusive. Bile acids (BAs) are ligands of farnesoid X receptor (FXR), a nuclear receptor of ligand-activated transcription factor. FXR has been shown to be highly involved in liver regeneration. BAs and FXR not only interact with each other but also regulate various downstream targets independently during liver regeneration. Moreover, recent findings suggest that tissue-specific FXR also contributes to liver regeneration significantly. These novel findings suggest that FXR has much broader role than regulating BA, cholesterol, lipid and glucose metabolism. Therefore, these researches highlight FXR as an important pharmaceutical target for potential use of FXR ligands to regulate liver regeneration in clinic. This review focuses on the roles of BAs and FXR in liver regeneration and the current underlying molecular mechanisms which contribute to liver regeneration.
format Online
Article
Text
id pubmed-4629218
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-46292182015-11-17 Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration Li, Guodong L. Guo, Grace Acta Pharm Sin B Review The liver is unique in regenerative potential, which could recover the lost mass and function after injury from ischemia and resection. The underlying molecular mechanisms of liver regeneration have been extensively studied in the past using the partial hepatectomy (PH) model in rodents, where 2/3 PH is carried out by removing two lobes. The whole process of liver regeneration is complicated, orchestrated event involving a network of connected interactions, which still remain fully elusive. Bile acids (BAs) are ligands of farnesoid X receptor (FXR), a nuclear receptor of ligand-activated transcription factor. FXR has been shown to be highly involved in liver regeneration. BAs and FXR not only interact with each other but also regulate various downstream targets independently during liver regeneration. Moreover, recent findings suggest that tissue-specific FXR also contributes to liver regeneration significantly. These novel findings suggest that FXR has much broader role than regulating BA, cholesterol, lipid and glucose metabolism. Therefore, these researches highlight FXR as an important pharmaceutical target for potential use of FXR ligands to regulate liver regeneration in clinic. This review focuses on the roles of BAs and FXR in liver regeneration and the current underlying molecular mechanisms which contribute to liver regeneration. Elsevier 2015-03 2015-02-20 /pmc/articles/PMC4629218/ /pubmed/26579433 http://dx.doi.org/10.1016/j.apsb.2015.01.005 Text en © 2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Li, Guodong
L. Guo, Grace
Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
title Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
title_full Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
title_fullStr Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
title_full_unstemmed Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
title_short Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
title_sort farnesoid x receptor, the bile acid sensing nuclear receptor, in liver regeneration
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629218/
https://www.ncbi.nlm.nih.gov/pubmed/26579433
http://dx.doi.org/10.1016/j.apsb.2015.01.005
work_keys_str_mv AT liguodong farnesoidxreceptorthebileacidsensingnuclearreceptorinliverregeneration
AT lguograce farnesoidxreceptorthebileacidsensingnuclearreceptorinliverregeneration